A new experimental platform facilitates assessment of the transcriptional and chromatin landscapes of aging yeast

Abstract

Replicative aging of Saccharomyces cerevisiae is an established model system for eukaryotic cellular aging. A limitation in yeast lifespan studies has been the difficulty of separating old cells from young cells in large quantities. We engineered a new platform, the Miniature-chemostat Aging Device (MAD), that enables purification of aged cells at sufficient quantities for genomic and biochemical characterization of aging yeast populations. Using MAD, we measured DNA accessibility and gene expression changes in aging cells. Our data highlight an intimate connection between aging, growth rate, and stress. Stress-independent genes that change with age are highly enriched for targets of the signal recognition particle (SRP). Combining MAD with an improved ATAC-Seq method, we find that increasing proteasome activity reduces rDNA instability usually observed in aging cells, and contrary to published findings, provide evidence that global nucleosome occupancy does not change significantly with age.

Data availability

We've included all processed data in easily accessible tables.Sequencing data have been deposited in GEO under accession codes GSE118581

The following data sets were generated
    1. Hendrickson DG
    2. Soifer I
    (2018) Genomic analysis of aging yeast
    Publicly available at the NCBI Gene Expression Omnibus (accession no: GSE118581).

Article and author information

Author details

  1. David G Hendrickson

    Calico Life Sciences, LLC, South San Francisco, United States
    Competing interests
    David G Hendrickson, Is affiliated with Calico Life Sciences. There are no other competing interests.
  2. Ilya Soifer

    Calico Life Sciences, LLC, South San Francisco, United States
    Competing interests
    Ilya Soifer, Is affiliated with Calico Life Sciences. There are no other competing interests.
  3. Bernd J Wranik

    Calico Life Sciences, LLC, South San Francisco, United States
    Competing interests
    Bernd J Wranik, Is affiliated with Calico Life Sciences. There are no other competing interests.
  4. Griffin Kim

    Calico Life Sciences, LLC, South San Francisco, United States
    Competing interests
    Griffin Kim, Is affiliated with Calico Life Sciences. There are no other competing interests.
  5. Michael Robles

    Calico Life Sciences, LLC, South San Francisco, United States
    Competing interests
    Michael Robles, Is affiliated with Calico Life Sciences. There are no other competing interests.
  6. Patrick A Gibney

    Calico Life Sciences, LLC, South San Francisco, United States
    Competing interests
    Patrick A Gibney, Is affiliated with Calico Life Sciences. There are no other competing interests.
  7. R Scott McIsaac

    Calico Life Sciences, LLC, South San Francisco, United States
    For correspondence
    rsm@calicolabs.com
    Competing interests
    R Scott McIsaac, Is affiliated with Calico Life Sciences. There are no other competing interests.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5339-6032

Funding

The authors declare that there was no funding for this work.

Copyright

© 2018, Hendrickson et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 13,285
    views
  • 1,375
    downloads
  • 56
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. David G Hendrickson
  2. Ilya Soifer
  3. Bernd J Wranik
  4. Griffin Kim
  5. Michael Robles
  6. Patrick A Gibney
  7. R Scott McIsaac
(2018)
A new experimental platform facilitates assessment of the transcriptional and chromatin landscapes of aging yeast
eLife 7:e39911.
https://doi.org/10.7554/eLife.39911

Share this article

https://doi.org/10.7554/eLife.39911

Further reading

    1. Computational and Systems Biology
    Nobuhisa Umeki, Yoshiyuki Kabashima, Yasushi Sako
    Research Article

    The RAS-MAPK system plays an important role in regulating various cellular processes, including growth, differentiation, apoptosis, and transformation. Dysregulation of this system has been implicated in genetic diseases and cancers affecting diverse tissues. To better understand the regulation of this system, we employed information flow analysis based on transfer entropy (TE) between the activation dynamics of two key elements in cells stimulated with EGF: SOS, a guanine nucleotide exchanger for the small GTPase RAS, and RAF, a RAS effector serine/threonine kinase. TE analysis allows for model-free assessment of the timing, direction, and strength of the information flow regulating the system response. We detected significant amounts of TE in both directions between SOS and RAF, indicating feedback regulation. Importantly, the amount of TE did not simply follow the input dose or the intensity of the causal reaction, demonstrating the uniqueness of TE. TE analysis proposed regulatory networks containing multiple tracks and feedback loops and revealed temporal switching in the reaction pathway primarily responsible for reaction control. This proposal was confirmed by the effects of an MEK inhibitor on TE. Furthermore, TE analysis identified the functional disorder of a SOS mutation associated with Noonan syndrome, a human genetic disease, of which the pathogenic mechanism has not been precisely known yet. TE assessment holds significant promise as a model-free analysis method of reaction networks in molecular pharmacology and pathology.

    1. Computational and Systems Biology
    2. Genetics and Genomics
    Eric V Strobl, Eric Gamazon
    Research Article

    Root causal gene expression levels – or root causal genes for short – correspond to the initial changes to gene expression that generate patient symptoms as a downstream effect. Identifying root causal genes is critical towards developing treatments that modify disease near its onset, but no existing algorithms attempt to identify root causal genes from data. RNA-sequencing (RNA-seq) data introduces challenges such as measurement error, high dimensionality and non-linearity that compromise accurate estimation of root causal effects even with state-of-the-art approaches. We therefore instead leverage Perturb-seq, or high-throughput perturbations with single-cell RNA-seq readout, to learn the causal order between the genes. We then transfer the causal order to bulk RNA-seq and identify root causal genes specific to a given patient for the first time using a novel statistic. Experiments demonstrate large improvements in performance. Applications to macular degeneration and multiple sclerosis also reveal root causal genes that lie on known pathogenic pathways, delineate patient subgroups and implicate a newly defined omnigenic root causal model.